on BV Holding AG (isin : CH0013396012)
SKAN Reports Preliminary Figures for 2025 Financial Year
On January 26, 2026, SKAN Group AG announced its preliminary, unaudited financial figures for the fiscal year 2025. The company, a leader in aseptic production systems for the pharma and biotech sector, anticipates net sales of approximately CHF 332 million, a decrease from the CHF 361.3 million reported in 2024. EBITDA is projected at CHF 38 million, down from CHF 57 million in the previous year. Despite these reductions, order intake is expected to rise slightly to CHF 365 million compared to CHF 359.5 million in 2024.
SKAN plans to release its comprehensive 2025 financial results on March 24, 2026, with an event scheduled in Zurich for stakeholders. The company remains a key partner globally, employing around 1700 people across multiple countries, with over half based in Allschwil, Switzerland.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BV Holding AG news